ATE87826T1 - Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen. - Google Patents

Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.

Info

Publication number
ATE87826T1
ATE87826T1 AT87900613T AT87900613T ATE87826T1 AT E87826 T1 ATE87826 T1 AT E87826T1 AT 87900613 T AT87900613 T AT 87900613T AT 87900613 T AT87900613 T AT 87900613T AT E87826 T1 ATE87826 T1 AT E87826T1
Authority
AT
Austria
Prior art keywords
metal complexes
purpurin
chlorin
purpurins
chlorins
Prior art date
Application number
AT87900613T
Other languages
English (en)
Inventor
Alan R Morgan
Steven H Selman
Martha Kreimer-Birnbaum
Original Assignee
Univ Toledo
Ohio Med College
Saint Vincent Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toledo, Ohio Med College, Saint Vincent Medical Center filed Critical Univ Toledo
Application granted granted Critical
Publication of ATE87826T1 publication Critical patent/ATE87826T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT87900613T 1986-01-02 1986-12-31 Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen. ATE87826T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81571486A 1986-01-02 1986-01-02
US84212586A 1986-03-18 1986-03-18
EP87900613A EP0256036B1 (de) 1986-01-02 1986-12-31 Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen
PCT/US1986/002824 WO1987004071A1 (en) 1986-01-02 1986-12-31 Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions

Publications (1)

Publication Number Publication Date
ATE87826T1 true ATE87826T1 (de) 1993-04-15

Family

ID=27123989

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87900613T ATE87826T1 (de) 1986-01-02 1986-12-31 Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.

Country Status (5)

Country Link
EP (1) EP0256036B1 (de)
AT (1) ATE87826T1 (de)
CA (1) CA1340951C (de)
DE (1) DE3688253T2 (de)
WO (1) WO1987004071A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5109129A (en) * 1989-09-29 1992-04-28 The University Of Toledo, Medical College Of Ohio Porphyrin derivatives
US5250668A (en) * 1988-01-11 1993-10-05 Morgan Alan R Production and use of porphyrin derivatives and of compositions containing such derivatives
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
WO1995031197A1 (en) * 1994-05-13 1995-11-23 Monsanto Company Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
CN1090633C (zh) * 1999-10-28 2002-09-11 许德余 叶绿素a降解产物金属络合物、其制备方法及抗胃溃疡药物
US6605606B1 (en) * 2000-08-04 2003-08-12 Miravant Pharmaceuticals, Inc. Solid forms of tin ethyl etiopurpurin and processes for producing such forms
RU2183956C1 (ru) * 2001-03-30 2002-06-27 Общество с ограниченной ответственностью "РАДА-ФАРМА" Фотосенсибилизатор и способ его получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581840B2 (en) * 1982-09-27 1989-03-09 Health Research Inc. Porphyrin derivatives
DE142732T1 (de) * 1983-10-24 1985-11-21 Toyo Hakka Kogyo K.K., Okayama Pheophorbidderivate und diese enthaltende pharmazeutische mittel.
JPS6092287A (ja) * 1983-10-24 1985-05-23 Toyo Hatsuka Kogyo Kk ９−デスオキソ−９−ハイドロオキシ−フエオホ−バイド誘導体およびそれらのアルカリ塩類

Also Published As

Publication number Publication date
EP0256036B1 (de) 1993-04-07
EP0256036A4 (de) 1989-11-30
DE3688253D1 (de) 1993-05-13
EP0256036A1 (de) 1988-02-24
WO1987004071A1 (en) 1987-07-16
CA1340951C (en) 2000-04-11
DE3688253T2 (de) 1993-09-02

Similar Documents

Publication Publication Date Title
Roberts et al. Photodynamic therapy of primary skin cancer: a review
Daniell et al. A history of photodynamic therapy
Szeimies et al. Topical photodynamic therapy in dermatology
Mullooly et al. Dihematoporphyrin ether‐induced photosensitivity in laryngeal papilloma patients
ATE87826T1 (de) Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.
LU90718I2 (fr) Visudyne-verteporfin et ses d-riv-s pharmaceutiquement acceptables
NZ292854A (en) Use of an photoactive compound to treat multiple sclerosis which is followed by light therapy
CA2133741A1 (en) Photochemotherapeutic method using 5-aminolevulinic acid and precursor thereof
ATE74006T1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE947222T1 (de) Verfahren zur Aktivierung von photoempfindlichen Mitteln
DK179286D0 (da) Insulinpraeparat
GB8824869D0 (en) Synthetic antibody
RU94046426A (ru) Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении
EP0295280B1 (de) Verwendung von Zinn-Protoporphyrin und Zinn-Mesoporphyrin zur Herstellung eines Arzneimittels für die Behandlung von Psoriasis
DE3782498D1 (de) Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten.
Petrozzi et al. Topical methoxsalen and blacklight in the treatment of psoriasis
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
Willis et al. Resistant psoriasis: Combined methoxsalen-anthralin therapy
Land Porphyrin phototherapy of human cancer
Ely Dermatologic therapies you’ve probably never heard of
Berns et al. Porphyrin sensitized phototherapy
ATE67672T1 (de) Protein c-inhibitor (pci) als pharmazeutikum und diagnostikum, verfahren zu herstellung eines solchen pharmazeutikums oder diagnostikums sowie ein mittel enthaltend pci.
Johnson et al. Persistence of skin color and fluorescence after treatment with dihydroxyacetone
RU2029489C1 (ru) Способ лечения асцита при портальной гипертензии
SU1604383A1 (ru) Способ лечени ишемической болезни сердца

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time